This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Meyer Bio-Medicine Co., Ltd., Shandong Academy of Pharmaceutical Sciences, Shandong Freda Pharmaceutical Group Co., Ltd.. Active years: 2022-2024.
IDiyas Innovation Intelligence. (2026). Inventor Profile: Huarong Shao. Retrieved from https://idiyas.com/inventor/huarong-shao
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
USPTO Granted Patents = 2 (Patent Applications = 1)
% Patents Active = 100.0
EPO Patents = 1
Average Co-Inventor Count = 4.7
ph-index = 1
Company Filing History:
Meyer Bio-Medicine Co., Ltd.
Shandong Academy of Pharmaceutical Sciences
Shandong Freda Pharmaceutical Group Co., Ltd.
4. 1 out of 1
Shandong Guantianxia Biotechnology Co., Ltd.
5. 1 out of 1
Shandong Meimao Pharmaceutical Co., Ltd.
where one patent can have more than one assignee
Years Active: 2022-2024
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents
Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
1 patent pending:
IDiyas Innovation Intelligence. (2026). Inventor Profile: Huarong Shao. Retrieved from https://idiyas.com/inventor/huarong-shao
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
1 patent (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]